Researchers has demonstrably improved the development of an novel solution for cardiac amyloidosis, utilizing Attruby. Preliminary trial data suggests significant improvements for those affected with this severe illness. This effort represents BridgeBio's focus to managing unmet medical needs in a heart arena. Attruby: BridgeBio's Novel… Read More